Metraipolis › archive › dc_93baf857321f

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data — Europe PMC PMID:38197648

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38197648
DOI
10.1289/ehp13233
License (as archived)
CC0-1.0
Archived
2026-10-07T11:28:52.759Z
SHA-256 of the archived text
d61af755c2cb5acb878f6124d55115f4a3794af932716a1a0e41efb671a32984
Stable URL of this page
https://metraipolis.com/documento/dc_93baf857321f

How to cite

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data — Europe PMC PMID:38197648 — Europe PMC (en), https://europepmc.org/article/MED/38197648 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_93baf857321f (Metraipolis archive dc_93baf857321f, sha256 d61af755c2cb5acb878f6124d55115f4a3794af932716a1a0e41efb671a32984)
BibTeX
@misc{dc93baf857321f,
  title = {Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data — Europe PMC PMID:38197648},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38197648},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_93baf857321f; sha256 d61af755c2cb5acb878f6124d55115f4a3794af932716a1a0e41efb671a32984},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38197648. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Chemicals that induce mammary tumors in rodents or activate estrogen or progesterone signaling are likely to increase breast cancer (BC) risk. Identifying chemicals with these activities can prompt steps to protect human health. Objectives: We compiled data on rodent tumors, endocrine activity, and genotoxicity to assess the key characteristics (KCs) of rodent mammary carcinogens (MCs), and to identify other chemicals that exhibit these effects and may therefore increase BC risk. Methods: Using authoritative databases, including International Agency for Research on Cancer (IARC) Monographs and the US Environmental Protection's (EPA) ToxCast, we selected chemicals that induce mammary tumors in rodents, stimulate estradiol or progesterone synthesis, or activate the estrogen receptor (ER) in vitro . We classified these chemicals by their genotoxicity and strength of endocrine activity and calculated the overrepresentation (enrichment) of these KCs among MCs. Finally, we evaluated whether these KCs predict whether a chemical is likely to induce mammary tumors. Results: We identified 279 MCs and an additional 642 chemicals that stimulate estrogen or progesterone signaling. MCs were significantly enriched for steroidogenicity, ER agonism, and genotoxicity, supporting the use of these KCs to predict whether a chemical is likely to induce rodent mammary tumors and, by inference, increase BC risk. More MCs were steroidogens than ER agonists, and many increased both estradiol and progesterone. Enrichment among MCs was greater for strong endocrine activity vs. weak or inactive, with a significant trend. Discussion: We identified hundreds of compounds that have biological activities that could increase BC risk and demonstrated that these activities are enriched among MCs. We argue that many of these should not be considered low hazard without investigating their ability to affect the breast, and chemicals with the strongest evidence can be targeted for exposure reduction. We describe ways to strengthen hazard identification, including improved assessments for mammary effects, developing assays for more KCs, and more comprehensive chemical testing. https://doi.org/10.1289/EHP13233.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2024 (prima pubblicazione 2024-01-10).
Identificativi: PMID 38197648 · PMCID PMC10777819 · DOI 10.1289/ehp13233.
Descrittori MeSH principali: Breast Neoplasms; Carcinogens; Endocrine Disruptors.
Pagina: https://europepmc.org/article/MED/38197648 — https://doi.org/10.1289/ehp13233. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:17:10.486Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.